Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HESKA CORPHSKA · Entity 112345 | VP, Chief Financial Officer | August 30, 2017 | August 31, 2017 |
| ModivCare IncMODV · Entity 76927 | Chief Accounting Officer | February 10, 2021 | February 12, 2021 |
| Option Care Health, Inc.BIOS · Entity 4126 | Chief Accounting Officer | October 29, 2018 | October 31, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HESKA CORP
Report date August 30, 2017 · Filed August 31, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68 |
Ending reported balance
After 2017-08-30 transaction · row 23
23 source rows · reconciled sequenceRow 1 · 2017-08-30 · Exercise / conversion · Acquired 125 · Balance 193 Row 2 · 2017-08-30 · Exercise / conversion · Acquired 148 · Balance 341 Row 3 · 2017-08-30 · Exercise / conversion · Acquired 583 · Balance 924 Row 4 · 2017-08-30 · Exercise / conversion · Acquired 1,752 · Balance 2,676 Row 5 · 2017-08-30 · Sale · Disposed 100 · Balance 2,576 Row 6 · 2017-08-30 · Sale · Disposed 100 · Balance 2,476 Row 7 · 2017-08-30 · Sale · Disposed 100 · Balance 2,376 Row 8 · 2017-08-30 · Sale · Disposed 100 · Balance 2,276 Row 9 · 2017-08-30 · Sale · Disposed 100 · Balance 2,176 Row 10 · 2017-08-30 · Sale · Disposed 300 · Balance 1,876 Row 11 · 2017-08-30 · Sale · Disposed 300 · Balance 1,576 Row 12 · 2017-08-30 · Sale · Disposed 300 · Balance 1,276 Row 13 · 2017-08-30 · Sale · Disposed 100 · Balance 1,176 Row 14 · 2017-08-30 · Sale · Disposed 21 · Balance 1,155 Row 15 · 2017-08-30 · Sale · Disposed 85 · Balance 1,070 Row 16 · 2017-08-30 · Sale · Disposed 85 · Balance 985 Row 17 · 2017-08-30 · Sale · Disposed 15 · Balance 970 Row 18 · 2017-08-30 · Sale · Disposed 102 · Balance 868 Row 19 · 2017-08-30 · Sale · Disposed 100 · Balance 768 Row 20 · 2017-08-30 · Sale · Disposed 100 · Balance 668 Row 21 · 2017-08-30 · Sale · Disposed 100 · Balance 568 Row 22 · 2017-08-30 · Sale · Disposed 200 · Balance 368 Row 23 · 2017-08-30 · Sale · Disposed 300 · Balance 68 |
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.39 · Expires 2025-10-13 | Direct | 1,084 |
Reported balance
After 2017-08-30 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2017-08-30 · Exercise / conversion · Disposed 125 · Balance 1,084 |
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.76 · Expires 2025-12-28 | Direct | 4,084 |
Reported balance
After 2017-08-30 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2017-08-30 · Exercise / conversion · Disposed 583 · Balance 4,084 |
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.85 · Expires 2026-12-28 | Direct | 1,923 |
Reported balance
After 2017-08-30 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2017-08-30 · Exercise / conversion · Disposed 148 · Balance 1,923 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.85 · Expires 2026-12-28 | Direct | 7,577 |
Reported balance
After 2017-08-30 transaction · row 27
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 27 · 2017-08-30 · Exercise / conversion · Disposed 1,752 · Balance 7,577 |
ModivCare Inc
Report date February 10, 2021 · Filed February 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,147 |
Reported balance
After 2021-02-10 transaction · row 1
1 source rowRow 1 · 2021-02-10 · Grant · Acquired 398 · Balance 1,147 F1: Represents restricted stock units scheduled to vest as follows: (1) 133 shares will vest on February 10, 2022, (2) 132 shares will vest on February 10, 2023, and (3) 133 shares will vest on February 10, 2024, in each case, subject to Mr. McMahon's continued employment. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.24 · Expires 2026-02-10 | Direct | 1,391 |
Reported balance
After 2021-02-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-10 · Grant · Acquired 1,391 · Balance 1,391 F2: This option will become fully exercisable as follows: (1) 464 options will vest on February 10, 2022, (2) 463 options will vest on February 10, 2023, and (3) 464 options will vest on February 10, 2024, in each case, subject to Mr. McMahon's continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units scheduled to vest as follows: (1) 133 shares will vest on February 10, 2022, (2) 132 shares will vest on February 10, 2023, and (3) 133 shares will vest on February 10, 2024, in each case, subject to Mr. McMahon's continued employment.
F2: This option will become fully exercisable as follows: (1) 464 options will vest on February 10, 2022, (2) 463 options will vest on February 10, 2023, and (3) 464 options will vest on February 10, 2024, in each case, subject to Mr. McMahon's continued employment.
Option Care Health, Inc.
Report date October 29, 2018 · Filed October 31, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2028-10-29 | Direct | 39,998 |
Reported balance
After 2018-10-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-10-29 · Grant · Acquired 39,998 · Balance 39,998 F1: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 25,943 |
Reported balance
After 2018-10-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-10-29 · Grant · Acquired 25,943 · Balance 25,943 F2: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3: The Restricted Stock Units vests in three equal annual installments commencing on the first anniversary of the date of grant. F4: The Restricted Stock Units vests in three equal annual installments commencing on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
F2: Each restricted stock unit represents a contingent right to receive one share of Common Stock.
F3: The Restricted Stock Units vests in three equal annual installments commencing on the first anniversary of the date of grant.
F4: The Restricted Stock Units vests in three equal annual installments commencing on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 200 | $65.50 | $13,100.00 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 14 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 100 | $66.03 | $6,603.00 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 13 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 200 | $65.78 | $13,156.00 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 12 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 175 | $65.65 | $11,488.75 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 11 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 327 | $65.64 | $21,464.28 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 10 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 25 | $65.63 | $1,640.75 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 9 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,045 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 466 | $65.62 | $30,578.92 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 8 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 100 | $65.61 | $6,561.00 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 7 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,536 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 7 | $65.60 | $459.20 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 6 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,636 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 300 | $65.59 | $19,677.00 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 5 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 55 | $65.58 | $3,606.90 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 4 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,943 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | SaleCommon Stock | 44 | $65.53 | $2,883.32 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 3 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,998 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | Exercise / conversionCommon Stock | 1,458 | $39.76 | $57,970.08 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 2 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:17 UTC | HESKA CORP HSKA · Entity 112345 | Exercise / conversionCommon Stock | 541 | $28.39 | $15,358.99 |
DisclosureSEC source: 0001038133-16-000335 · edgardoc.xml · nonDerivative · entry 1 McMahon John · CIK 0001499911 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.